First order of the Risk Committee business:
- set timeframe for PR to relinquish his dual roles
- risk assess existing teams ability to coordinate +120 clinical sites for P3 including timeframes, standardisation of treatment scripting delivery to manage placebo
- mandatory vetting of ASX releases for inconsistency from risk and legal experts
- establish tracking log for key milestones and publicly stated prior committeements eg peer reviews
- review Board and Exec REM benchmarking to confirm independence of source
- Hire a Board member with actual risk and compliance experience that is capable of standing their ground and not forced to move on under false pretences
- Etc etc etc
First order of the Risk Committee business:- set timeframe for...
-
- There are more pages in this discussion • 199 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.005(2.17%) |
Mkt cap ! $82.20M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 23.5¢ | 23.0¢ | $85.35K | 365.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 280011 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 44703 | 3 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |